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Review
The term “organophosphate” (OP) is often 
used in the scientific and lay press to describe 
a large chemical class of insecticides and 
chemi  cal warfare agents. OP insecticides, 
which include malathion and chlorpyrifos, 
among others, are among the most widely 
used agrochemicals for the control of insect 
pests in the world. Approximately 427 tons of 
OP insecticides were used for vector control in   
2003–2005 (Zaim and Jambulingam 2007), 
and > 36.5 million tons were used in agri-
culture in the United States in 2001 [Barr 
et al. 2005; Centers for Disease Control 
and Prevention 2005; U.S. Environmental 
Protection Agency (EPA) 2006]. This level 
of use inevitably leads to increased human 
exposure and toxicity incidences both in the 
United States and worldwide (Claudio et al. 
2000; Goldman and Koduru 2000; Menzies 
and MacConnell 1998). A total of 136,881 
OP exposure incidents were reported to poi-
son control centers in the United States dur-
ing 1995–2004 (Sudakin and Power 2007), 
and in 2007 the American Association of 
Poison Control Centers received 96,307 calls 
associated with OP exposure (Bronstein et al. 
2008).
The principle trigger of neurotoxicity after 
exposure to OPs is presumed to result from 
the inhibition of acetyl  cholinesterase (AChE) 
(Ballantyne and Marrs 1992; Broomfield 
et al. 1995; Eto 1974; Fest and Schmidt 
1973; Fukuto 1990). When AChE is inhib-
ited by an OP, it is unable to hydrolyze the 
neuro  transmitter acetyl  choline (ACh), which 
reaches toxic concentrations in the neural syn-
apse, causing hyperstimulation of cholinergic 
receptors, resulting in tremors, lacrimation, 
and bradyarrhythmia and, if untreated, may 
become lethal (Costa 2006; Sultatos 1994). 
A number of non  cholinergic illnesses have 
also been linked to OPs, including ataxia, 
delayed neuropathy, intermediate syndrome, 
pulmonary toxicity, geno  toxicity, Parkinson 
disease, and vision loss (Arima et al. 2003; 
Dahlgren et al. 2004; Jayawardane et al. 2008; 
Niven and Roop 2004; Yanagisawa et al. 
2006; Zwiener and Ginsburg 1988). Widely 
reported but unsubstantiated health problems 
associated with OP exposure include flu-like 
symptoms, nausea, weakness, and dizziness 
(Gordon 1993; Rowsey and Gordon 1999; 
Solomon et al. 2007; Stephens et al. 1995). 
Low-dose OP exposure causes minimal inhi-
bition of AChE and no obvious cholinergic 
symptoms yet has been linked to memory loss, 
sleep disorder, depression, learning and lan-
guage impairment, and decreased motor skills 
in humans (Johal et al. 2007; Lockridge and 
Masson 2000; Slotkin et al. 2008; Timofeeva 
et al. 2008). Despite these numerous reports 
of OP-associated illnesses, few if any have 
been correlated with a specific protein, path-
way, or cellular event that has been modified, 
disrupted, or regulated by an OP.
Recent studies have associated adverse 
neurologic and growth outcomes in children 
exposed to certain OPs in utero (Jacobson and 
Jacobson 2006; Whyatt et al. 2004, 2005). 
A neuropsychological assessment of children 
exposed to OPs showed deficits in inhibitory 
motor control (Kofman et al. 2006). Two 
associated studies correlated developmental 
exposure with abnormal reflexes (Young et al. 
2005) and mental developmental problems 
(Eskenazi et al. 2007). OPs are thought to 
cause developmental neurotoxicity and long-
term cognitive and behavior effects through 
cholinergic mechanisms, interference with 
non  enzymatic functions of AChE, and effects 
on cell signaling pathways involved in neural 
cell differentiation (Slotkin 2004).
Many claims of illness due to OP-based 
exposure have not been correlated with dose 
largely because of inadequate methods of 
analysis and the transient nature of OP com-
pounds. The environmental lifetime of OP 
insecticides is typically considered to be rapid 
(days), but in indoor applications certain 
OPs can survive intact from months to years 
(Fenske et al. 2000). Still, the rapid break-
down of OPs in vivo or in the environ  ment 
makes their direct measurement challenging, 
and rough estimates or indirect measures of 
exposure are conducted by identification of 
OP metabolites or degradation products. For 
example, gas chromatography (GC) coupled 
with mass spectrometry (MS) has been used 
to analyze the primary metabolites of OP 
compounds, typically the hydrolyzed acids 
of dialkylphosphates [RO2P(O)OH] in urine 
(Barr et al. 2005).
For decades, exposure to OP insecticides 
has been determined using a blood cholin-
esterase test, a colorimetric assay in which a 
reduction in basal cholinesterase activity in 
whole blood or serum is used to indicate OP 
exposure (Ellman et al. 1961). Plasma butyryl-
cholinesterase (BChE) assays are used for the 
early, acute effects of OP exposure because 
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red blood cell AChE assays are less sensitive 
(Wilson et al. 1996). By design, the blood 
cholinesterase test measures only the “active” 
form of the enzyme, but it is the inactive or 
OP-adducted form of the enzyme that is the 
more quantifiable biomarker.
To address this, investigators have begun 
to employ computational, high-throughput, 
bioinformatic, and proteomic methods to 
identify and quantify molecular biomarkers 
to a number of environmental- and exposure- 
based diseases. For this review we identi-
fied general and specific research reports 
related to OP insecticides, OP toxicity, OP 
structure, and protein MS by searching 
PubMed (National Center for Biotechnology 
Information 2009) and Chemical Abstracts 
(Chemical Abstract Service, Columbus, OH) 
for articles published before December 2008. 
Here, we summarize the use of protein MS as 
a valuable tool to identify OP-adducted pro-
teins and as a potentially promising approach 
to deconvolute a number of OP-triggered 
illnesses. We also discuss MS analysis of pro-
teins adducted by chemical nerve agents and 
the use of customized probes for identifica-
tion of OP-modified proteins. To focus our 
discussion, we do not include genomic studies 
of protein regulation changes resulting from 
OP exposure or the MS of OP compounds.
Structure and Reactivity of OP 
Compounds
The overall class of organophosphorus (V) 
compounds includes a number of useful struc-
ture types, among which are the OPs, which 
are functional group derivatives of phosphoric 
acid and include ester (phosphate), amide 
(phosphoramidate), thiol  ester (phosphoro-
thiolate), difunctional and tri  functional forms, 
and combinations of these hetero  atomic link-
ages. Unlike the structurally similar carboxy-
lic acids, however, OP compounds can vary 
as phosphoryl (P=O) or as thio  phosphoryl 
(P=S). These subtle atomic differences lead 
to a wide array of structural types that vary 
dramatically in their chemical, physical, and 
biochemical properties. Importantly, the 
“ate” ending associated with heteroatom-
attached groups designates the structure as 
a phosphoric acid functional group deriva-
tive. This description also includes structures 
containing one phosphorus–carbon (P–C) 
group, termed a phosphonate, and two P–C 
groups, termed a phosphinate. When three 
P–C bonds occur, the structure is no lon-
ger a phosphoric acid derivative and there is 
no “ate” ending (e.g., Ph3P=O is triphenyl-
phosphine oxide). Because most insecticides 
contain three phosphorus-heteroatom groups, 
the term “organophosphate” is both useful 
and chemically accurate for the purposes of 
this review. However, “organophosphorus 
insecticide” is a useful description and supe-
rior when searching certain databases.
Malathion, parathion, chlor  pyrifos, azin-
phos, and diazinon are representative OP 
insecticides (Figure 1, structure 1). These OP 
insecticides are structurally similar and share 
diester and thionate (P=S) groups. For exam-
ple, parathion, chlor  pyrifos, and diazinon are 
diethyl phosphoro  thionates that vary only in 
the leaving group (Z; see Figure 1). Malathion 
and azinphos have a thiol as the leaving group. 
When both P=S and P–SR groups are present, 
the structure is a thiolothionate, or the more 
general term, dithioate. Although an exten-
sive examination of OP insecticide structure is 
beyond the scope of this review, it is important 
to note that when leaving group differences 
are ignored, most OP insecticides fall into just 
two general classes: dimethoxy OP (DMOP) 
and diethoxy OP (DEOP). A smaller frac-
tion of OP insecticides do not share these 
structural traits; acephate, for example, is a 
phosphor  amidate with an oxon (P=O) bond 
and a phosphoramide (P–N) bond. 
For OP insecticides to impart their action, 
they first require a change in structure from 
a thionate to an oxon (structures 1 and 2, 
respectively, in Figure 1). The oxon is mark-
edly more reactive and likely the primary 
chemical species responsible for most inter-
actions with bio  molecules as well as a key 
intermediate in route to hydrolytic metabo-
lites. After an OP insecticide is converted 
to the oxon, it is known to react quickly 
with certain proteins to form OP adducts 
(Figure 2). A governing property of most 
OPs, therefore, is that they covalently modify 
proteins to form OP-adducted proteins in 
which protein function can be compromised 
concomitant with an increase in the pro-
tein’s molecular weight due to the addition 
of the OP. Covalent modification or organo-
phosphorylation of a protein is a distinctive 
process because most organic and inorganic 
compounds transiently bind or form com-
plexes with proteins but less frequently form a 
covalent bond with the protein.
Phosphorylation by insecticides is best 
exemplified by the inhibition of the primary 
target of OP insecticides, AChE (Figure 2). 
OP inhibition occurs at an essential serine 
(ser) residue synchronous with the ejection 
of a leaving group (Z) to yield a stable cova-
lent bond, forming an OP–AChE adduct. 
OP-inhibited AChE can then reactivate   
(kreact) via cleavage of the phospho  serine bond 
(Ashani et al. 1990, 1995, 1998; Langenberg 
et al. 1988; Lanks and Seleznick 1981; 
Wilson and Henderson 1992; Wilson et al. 
1992) or undergo “aging” (Harel et al. 1991), 
a slow, irreversible process (kaging << ki) that 
results in an OP–AChE adduct that contains 
a phosphate oxyanion (Doorn et al. 2000; 
Lotti et al. 1984).
The overall mechanism of AChE inhibi-
tion, reactivation, and aging by OP oxons is 
highly conserved because most OP insecti-
cide oxons bear either dimethoxy or diethoxy 
groups. Therefore, loss of the leaving group Z 
affords two predominant forms of OP–AChE 
adducts: the DMOP (R=Me) and DEOP 
(R=Et). DEOP-adducted AChE is expected 
to be more stable and slower to reactivate and 
should undergo aging (correlated with the 
increased size of the R group). The di  methoxy 
analog should reactivate more rapidly and 
undergo less aging, although methyl esters 
undergo hydrolysis more rapidly than do 
ethyl esters. OP insecticide oxons, there-
fore, adduct AChE to form DMOP–AChE 
and DEOP–AChE structures that lead to 
Figure 1. Structure of OP insecticides and select 
OP agents. Abbreviations: Et, ethyl; Me, methyl; 
Ph, phenyl. For malathion, R = Me, Z = SCH(CO2Et)
CH2CO2Et; parathion, R = Et, Z = O–Ph–p–NO2; chlo-
rpyrifos, R = Et, Z = o-2,3,5-trichloropyridinol; azin-
phos, R = Et, Z = SCH2–3-benzenetriazole-4-one; 
diazinon, R = Et, Z = O[6-Me, 4-iPr-pyrimidi  nol]. 
Parathion, chlorpyrifos, azinphos, and diazinon are 
also available as dimethyl esters. 
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Figure 2. Formation of OP oxon and reactions with AChE. Abbreviations: kaging, aging (nonreactivation) rate con-
stant; ki, inhibition rate constant; kreact, reactivation rate constant. 
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two aged forms, monomethoxy phos  phoryl 
(Y=OMe) and monoethoxy phosphoryl 
(Y=OEt) (Figure 2), respectively. These con-
vergent mechanisms furnish investigators 
with some preliminary molecular targets for 
defining the OP proteome (the complement 
of proteins found in cells, tissues, or organ-
isms that react with OP compounds) because 
the overall mechanism of organophos-
phorylation is most likely conserved for most 
other proteins (e.g., receptors, enzymes). In a 
like manner, OP oxons of any structure can 
modify AChE or any protein with a reactive 
residue if a suitable leaving group Z is pres-
ent. In the case of the general OP structure 
(Figure 1, structure 3), loss of the Z group 
would generate a protein-bearing XYP(O) 
group attached to a serine. 
A key difference is that biochemical phos-
phorylation and dephosphorylation, which 
are mediated by kinases and phosphatases, 
result in the addition and loss of an inor-
ganic PO4
2– group. Although this is clearly 
different from the organophosphorylation 
process, it is entirely possible that OP insec-
ticide oxons react with the same proteins 
that are substrates of kinases/phosphatases. 
Posttranslational phosphorylation is relatively 
well understood and is now a routine part of 
proteomics analysis (Godovac-Zimmermann 
et al. 1999; Larsen et al. 2001).
The Search for OP Biomarkers: 
Possible Pathways
Toxic effects due to OP exposure likely begin 
with covalent modification (adduction) of a 
protein and thereby constitute an early bio-
marker of exposure. For example, the well-
documented OP neurotoxic pathologies are 
believed to result either directly or indirectly 
from stepwise phosphorylation of AChE 
(OP–AChE adduct), cholinergic hyper-
stimulation, and resultant cellular responses 
(Figure 3, top pathway). However, the con-
nection between OP–protein adducts other 
than AChE and the resulting cellular/toxic 
responses have not been established (Figure 3, 
bottom pathway). A clearer understanding of 
how alternate cellular pathways are modulated, 
altered, or blocked in response to OP expo-
sure is needed so that more accurate, pathway-
  oriented biomarkers can be identified.
More recently, investigators have begun 
to investigate covalent OP adduction of non-
AChE protein targets as a possible causative 
step in other toxic responses. The involvement 
of OPs at individual ACh receptors (nAChR, 
mAChR) and non  cholinergic protein targets 
has been reported with increasing frequency 
(Albuquerque et al. 1988; Bomser and Casida 
2001; Corrigan et al. 1994; Ehrich et al. 
1994; Eldefrawi and Eldefrawi 1983; Huff 
et al. 1994; Katz and Marquis 1992; Li et al. 
2000a, 2000b; Pala et al. 1991; Quistad and 
Casida 2000; Quistad et al. 2000, 2001; 
Richards et al. 1999; Schuh et al. 2002; 
van den Beukel et al. 1998; Ward et al. 1993; 
Ward and Mundy 1996). However, only a 
few investigations have identified OP-altered 
protein targets, despite the clear evidence sug-
gesting involvement in toxic mechanisms. In 
a biomarker search, investigators can point to 
pathways that individually or collectively may 
correlate with various mechanisms of toxic-
ity (e.g., Figure 3). Overall, OP compounds 
react with AChE to form an OP–AChE 
adduct (Figure 3, top pathway) and also with 
other yet uncharacterized and unidentified 
proteins to form OP–protein adducts that 
trigger new cellular outcomes (Figure 3, bot-
tom pathway) and/or produce OP-adducted 
biomolecules that directly modulate, regulate, 
or shut down biochemical pathways (Bomser 
and Casida 2000, 2001; Bomser et al. 2002). 
Clearly, integrative proteomic and genomic 
approaches are needed to charac  terize these 
OP–protein biomarkers and validate them 
with any downstream effects. Such infor-
mation would be invaluable for therapeu-
tic intervention; body burden and tolerance; 
identification of genetic, age, race, and sex 
susceptibility; exposure prevention; and the 
overall assessment of OP safety.
Protein MS 
Proteomics and protein MS are powerful diag-
nostic methods to analyze and identify pro-
teins and their modifications based on the 
molecular weight of peptide fragments result-
ing from enzymatic digestion. These meth-
ods can be conducted with a variety of mass 
analysis instruments, of which matrix-assisted 
laser desorption ionization (MALDI) and   
quadrupole-time of flight (QTOF) are among 
the most common in OP–protein studies. 
MALDI offers high-throughput, medium-
resolution mass analysis (fingerprinting) of 
peptides and can also mass identify proteins 
after formulation with a matrix. MALDI is 
relatively easy to use and requires no chro-
matographic separation of the peptide digest, 
although separation of peptides can greatly 
assist identification. Most QTOF instru-
ments use electrospray ionization (ESI) and 
allow for direct injection or use of HPLC 
(high-performance liquid chromatography) 
for separa  tion of peptide analytes before 
MS. QTOF instruments are high-resolution 
instruments that can identify peptides using 
sequence information to provide greater sta-
tistical validation of both peptide and pro-
tein. Ion-trap and triple-quadrupole mass 
spectrometers are other instruments used in 
proteomics and protein MS experiments. 
Although MALDI and QTOF instruments 
use databases to identify peptides and the pro-
tein, the sequence information and mass accu-
racy provided by the QTOF ensure a more 
accurate peptide match and protein identifica-
tion. An additional consideration in choice of 
mass spectrometer is the mass-to-charge ratio 
(m/z), which plays a role in the size of the pep-
tide that can be analyzed accurately. Standard 
MALDI experiments detect single-charged 
peptides, meaning the instrumental mass 
observed correlates with the peptide mass. 
QTOF electro  spray instruments (and other 
ion-based MS techniques) can detect singly, 
doubly, and triply charged peptide ions (e.g., a 
peptide weighing 4,200 m/z affords 2,100 m/z 
for a doubly charged ion and 1,400 m/z for a 
triply charged ion), which can be an advantage 
in the identification and sequencing of large-
molecular-weight peptides.
Both instruments are useful to analyze 
OP-modified protein adducts, but certain 
ionization methods (or cone voltages) used 
by electro  spray MS instruments may cause 
cleavage of the somewhat labile phospho-
ester bonds formed with serine, threonine, 
or tyrosines (Figure 4). The loss of a (post-
translational) phosphate group from a 
peptide during electro  spray MS analysis 
(X=Y=O–) can restore the serine residue or 
cause an elimination reaction that results in 
a dehydroalanine residue via the net loss of 
a water mole  cule (m/z 18) from the peptide 
(Figure 4). In addition to ionization condi-
tions, the matrix used in MALDI may play 
a role in the stability of phospho  ester link-
age and its mass analysis. Several key studies 
and useful reviews have been published on 
MS-based dephosphorylation (reviewed by 
Sickmann and Meyer 2001) and will be help-
ful to those seeking to investigate OP–protein 
adducts (Adamczyk et al. 2001; Bennett et al. 
Figure 3. Common sequence of cholinergic events and alternate sequence after OP exposure. The white 
pathway (top) shows the stepwise phosphorylation of AChE (OP–AChE adduct), cholinergic hyperstimula-
tion, and resultant cellular responses. The blue pathway (bottom) shows possible connections between 
OP–protein adducts other than AChE and the resulting cellular/toxic responses. 
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2002; Jiang and Wang 2004; Qian et al. 
2003; Thaler et al. 2003; Tseng et al. 2005). 
The use of barium hydroxide [Ba(OH)2] to 
induce formation of the dehydro  alanine resi-
due as a method to identify phosphorylation 
(Noort et al. 2006) is discussed below (see 
“MS Analysis of OP-Modified Proteins in 
Addition to Cholinesterases”).
MS of Cholinesterases and Their 
Active Site-Containing Peptides
Historically, AChE and BChE are the prin-
cipal targets covalently modified by OP com-
pounds. Specifically, covalent modification 
of the essential serine residue (Figure 2) on 
AChE is of prime importance in MS analy-
ses because this step initiates neuro  toxic 
events. OP attachment to the serine residue 
represents the predominant if not definitive 
chemical pathway for analysis. Therefore, 
the molecular events that define esterase 
OP inhibition (including reactivation and 
aging; Figure 2) are likely to be similar to 
serine hydrolases, serine proteases, and other 
related proteins. Still, the assumption that 
serine is the only location for modification by 
OPs may be invalid, and steps are needed to 
develop methodology capable of identifying 
other OP-residue modifications.
First, it is important to show how 
OP–ChE adducts are identified by MS. In a 
typical experiment, a cholinesterase is inhib-
ited by an OP; the protein–ChE adduct is 
isolated; the protein is digested into peptide 
fragments (trypsin, chymotrypsin, etc.); the 
peptides are analyzed by MS; and the modi-
fied OP–peptide is identified using a database 
match. A high degree of conservation in the 
primary sequences of AChE and BChE has 
enabled rapid identification of OP-modified 
peptides from various species. Tied to this 
advantage is the obvious site of OP modifica-
tion: the catalytically active site serine. Unlike 
most investigations that require near complete 
N- to C-termini analysis to find one or more 
adducts, investigators have assumed that OP 
modification modifies only the active site ser-
ine hydroxyl. These two structural assump-
tions regarding cholinesterase reactivity toward 
OPs allowed investigators to narrow their mass 
analysis (ion selection) to a handful of peptide 
fragments, although multiple OP adducts are 
possible. Key to the OP–ChE protein adduct 
detection by MS, therefore, is the analy-
sis and identification of the corresponding 
OP-modified active-site peptide.
Although there are many methods for 
protein digestion, trypsin [cleaves at argin-
ine (R) or lysine (K) at the C-terminus], pep-
sin [cleaves at phenylalanine (F), tryptophan 
(W), or tyrosine (Y) at the N-terminus], and 
chymotrypsin (cleaves at F, W, or Y at the 
C-terminus) are the most widely used pepti-
dases. Cyanogen bromide [CNBr; cleaves at 
methionine (M)] has been used for chemical 
digestion before or after protease action. Key 
differences in the primary sequences of AChE 
and BChE result in active site-containing pep-
tide fragments (Figure 5) of different sizes after 
trypsin and chymotrypsin digests. Different 
sources of cholinesterase (horse, rat, mouse, 
fly, eel, etc.) will produce different peptide 
molecular weights because the sequence is not 
100% conserved. 
Likewise, CNBr chemical digestion pro-
duces peptides containing the active site; 
however, the methionine groups are spaced 
relatively far apart in the sequence. This results 
in larger peptides (Figure 5) that can be more 
difficult to analyze and identify. However, 
the combination of chemical and peptidase 
Figure 4. Dephosphorylation of peptides.
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digestions can be a powerful dual method for 
peptide analysis. In sum, understanding the 
predicted peptide fragments resulting from 
different digestion procedures allows research-
ers to plan their identification strategies.
There have been few attempts to map the 
entire AChE or BChE primary sequence using 
MS. Spaulding et al. (2006) sequenced a puri-
fied source of recombinant mouse AChE 
(rMoAChE) by ESI QTOF MS and found 
that the highest protein coverage (63%) and 
active-site peptide signal were achieved when 
the AChE:chymotrypsin ratio was 5:1. Some 
excellent early uses of MS to understand ChE 
structure were conducted by Rosenberry 
and colleagues, who deciphered the glyco-
inositol phospho  lipid anchor and protein 
C-terminus of BChE (Haas et al. 1996; Haas 
and Rosenberry 1995; Roberts et al. 1988).
One of the more recent benefits of MS 
is the ability to directly meas  ure the entire 
protein mass and, in turn, the possibility of 
directly measuring OP-adducted proteins by 
the corresponding increase in the native mass. 
Mechanistic studies such as these are facili-
tated when cholinesterase can be expressed in 
good quantity and pure form, which reduces 
interferences from more abundant proteins 
typically found in biological matrices. One 
of the earliest such studies directly measured 
human AChE (hAChE) mass at approxi  mately 
64,700 Da (calculated at 64,695 Da) and 
OP-adduct masses increased as a function of 
inhibitor structure (Barak et al. 1997). 
Identification of OP-Modified 
Cholinesterases by MS 
MS was used in early studies of mass shifts of 
AChE after OP exposure, including studies 
of chemical agents (Barak et al. 1997), insec-
ticide and chemical agents (Elhanany et al. 
2001), and insecticide impurities (Doorn 
et al. 2000). In these studies, the masses of 
whole protein and/or that of the active-site 
peptide were compared with the mass when 
bound to OP (less its leaving group). The 
influence of alkyl group size on aging (loss 
of an alkyl phospho  ester group after inhi-
bition) (Figure 6) was investigated using 
ESI-MS (Barak et al. 1997). Recombinant 
hAChE (64,700 Da) was inhibited by methyl-
phosphonate analogs, and the corresponding 
adducts CH3(RO)P(O)–hAChE, where R = 
iso  propyl (iPr), iso  butyl (iBu), 1,2-dimethyl-
propyl, and 1,2,2-trimethyl  propyl showed 
measured mass increases of approximately 
120, 140, 152, and 160 Da, representing 
the molecular weight of the added phospho-
nate group. Over time, each of the methyl-
phosphonate adducts lost its alkoxy group to 
aging and converged to a mass of 64,780 Da, 
a value that structurally correlates with forma-
tion of a P(O)(CH3)OH adduct. Aging and 
reactivation are intimately tied mechanisms 
for most OP inhibitors of AChE and they 
have direct application to OP insecticide 
inhibitors bearing alkoxy groups. 
Certain chemical agents and insecticides 
share the common structural feature of phos-
phoramide (P–N) group that can undergo 
aging. MALDI-TOF was used to identify 
the active-site peptide of AChE after trypsin 
digestion (Elhanany et al. 2001) by the phos-
phoramides tabun (chemical agent) and 
methamidophos (insecticide) (Figure 6). In 
an experiment designed to exploit the resolv-
ing power of MS, a hexa  deuterio analog of 
tabun was used to form OP–AChE adducts; 
after trypsin digestion, the active-site peptide 
adduct showed an increase of 6 mass units 
versus unlabeled tabun (Figure 6). Again, the 
peptide adducts were of identical mass. The 
mechanism of AChE inhibition by meth-
amidophos, previously shown to lose a thio-
methyl (Thompson and Fukuto 1982), was 
validated by observation of the correspond-
ing (MeO)(NH2)P(O)–peptide adduct and 
then formation of the free active-site pep-
tide after reactivation (Elhanany et al. 2001). 
Isomalathion, an impurity in the insecticide 
malathion (Figure 6), contains two stereo-
centers that cause the mechanism of inhi-
bition to occur via two pathways involving 
the loss of different leaving groups (Berkman 
et al. 1993a, 1993b, 1993c). A series of inves-
tigations by MALDI analysis of the active-site 
peptide determined that a single stereo  isomer 
of isomalathion produces aged AChE, that 
is, loss of both thioalkyl groups (Doorn et al. 
2000, 2001a, 2001b).
MALDI was used to study the cova-
lent adduction of rMoAChE by a series of 
dialkoxy phosphates that varied as dime-
thoxy, diethoxy, and diisopropoxy (Jennings 
et al. 2003). The tryptic active site-contain-
ing peptide for rMoAChE was identified at 
m/z 4331.0; inhibition by diethoxy paraoxon 
showed an increase in this native peptide by 
136 m/z. Likewise, inhibition by dimethoxy 
and diisopropoxy reactive OP compounds 
yielded the corresponding adducts (Figure 7). 
The MALDI experiments were correlated with 
kinetic analysis in the identification of the 
corresponding aged adducts for each alkoxy 
form. The ratio of inhibited, aged, and unin-
hibited forms of dimethyl phosphorylated 
AChE was delineated by their MS molecular 
weight signatures with tissue from a single 
mouse treated with sublethal doses of metri-
fonate (a DMOP inhibitor).
Chymotrypsin was used to digest 
rMoAChE into the smaller active-site contain-
ing peptide sequence GESAGAASVGMHIL 
(1298.62 Da) to more easily identify diethoxy 
and dimethoxy peptide adducts (Spaulding 
et al. 2006). A general method for detecting 
human OP–BChE adducts, reported by Noort 
et al. (2006), exploits the dehydroalanine- 
forming elimination mechanism from 
phosphoryl serines to tag proteins. BChE 
(from human plasma samples) that had 
been inhibited by OPs was digested with 
Figure 6. Structures of OP chemical agents and insecticide. 
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pepsin, converted to the dehydro  alanine resi-
due using Ba(OH)2, and reacted with amino 
or thiol nucleophiles to afford tagged peptides 
(Figure 8). The best results were achieved 
using 2-(3-aminopropylamino)ethanol to tag 
phosphylated BChE. The converted samples 
were then analyzed using liquid chromatog-
raphy and tandem MS to determine the loca-
tion of BChE modification by OPs. Because 
unmodified BChE does not form dehydro-
alanine, this method could be used to screen 
relatively large numbers of samples to detect 
OP exposure. The initial digest can then be 
analyzed more specifically to determine the 
identity of OP inhibitor.
MS Analysis of OP-Modified 
Proteins in Addition to 
Cholinesterases
Cholinesterases are not the only targets of 
reactive OP compounds, and other molecular-
level protein biomarkers have been identified 
with and without the aid of MS. Murray et al. 
(2005) found a number of adducted proteins 
in rat brain homogenates that were exposed to 
a variety of OPs (azamethiphos, chlorfenvin-
phos, diazinon, malathion, pirimiphos-methyl, 
and chlorpyrifos) at concentrations producing 
< 30% inhibition of brain AChE. Tritiated 
diisopropyl fluorophosphate was used to label 
protein targets not adducted by the test OP. 
Although the authors were not able to posi-
tively identify the protein targets, each of the 
six OPs tested adducted a different collection 
of proteins, suggesting that different OPs may 
produce their own specific form of toxicity 
(Murray et al. 2005).
Hundreds of serine hydrolases are expressed 
in the human proteome, and many are poten-
tial targets for OP adduction. Synthesis of 
customized OP probes [fluorophosphonates 
(FPs)] that attach an OP to biotin (FP-biotin; 
Figure 9) or fluorescent molecules such as 
rhodamine permit “fishing” of cell lysates to 
access or identify non-AChE targets that were 
not previously identified (Casida and Quistad 
2005). Examples of these enzymes include 
neuropathy target esterase, carboxyl  esterase, 
and platelet-activating factor acetylhydrolase 
as potential targets, as well as many other ser-
ine hydrolases. Nomura et al. (2006) identi-
fied serine hydrolase KIAA1363 that is diethyl 
phosphorylated in mouse brain by chlor  pyrifos 
oxon. Chlorpyrifos is a unique OP because 
it is highly lipophilic, and its leaving group 
is also implicated in certain toxicities. Blood 
acylpeptide hydrolase activity has been identi-
fied as a possible biomarker of OP exposure 
(Murray et al. 2005; Richards et al. 1999). In 
a number of detailed studies, Costa and col-
leagues advanced paraoxonase (PON1) and 
its isoforms as biomarkers of susceptibility to 
OP toxicity (Costa 1998; Costa et al. 2003, 
2005). In most studies, one protein or path-
way is identified to serve as a biomarker. But 
the measurement of one OP protein target, 
although valuable, can be questionable unless 
background exposure levels are relatively stable 
over time. Moreover, as outlined above, the 
OP-adduction step may not be the sole indi-
cator of an inter  action. This limitation holds 
true also for the traditional cholinesterase tests, 
metabolite analysis, and direct measurements.
Molecular probes such as FP-biotin 
(Figure 9) may serve as useful tools in analyz-
ing multiple proteins in complex protein sam-
ples (Adam et al. 2001, 2002; Grigoryan et al. 
2008; Kidd et al. 2001; Liu et al. 1999). The 
probe design contains a reactive OP moiety 
containing a fluoro leaving group and a bio-
tin “catch” group connected by a long linker 
group to allow the reactive OP to reach deep 
into protein structures. Ideally, a proteomic 
experiment will provide protein identification, 
expression levels, and the functional state of 
proteins. In studies aimed at profiling ser-
ine hydrolase activity, FP-biotin probes were 
used to selectively isolate and identify serine 
hydrolases in crude cell and tissue extracts 
and also for the functional characterization 
of these enzymes (Kidd et al. 2001; Liu et al. 
1999) (Figure 9). Although FP-biotins are 
excellent probes of serine hydrolases and other 
OP-reactive proteins, the long lipophilic 
Figure 8. Ba(OH)2-induced dephosphorylation to tag proteins. Adapted from Noort et al. (2006). Nuc, 
nucleophile. 
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tethers and attenuated reactivity as a phospho-
nate compared with phosphate likely select 
for a protein population different from that 
of the OP oxon structures. Thus, differences 
in reactivity and cell permeability properties 
of FP-biotin probes must be considered when 
assessing possible OP–protein biomarkers. 
In one study, Kidd et al. (2001) investi-
gated the rate differences in which the serine 
hydrolases react with FP-biotin probes after 
treatment with oleoyl trifluoro  methyl ketone 
(OTFMK), a reversible inhibitor of ser-
ine hydrolases. Serine hydrolase targets were 
identified directly in complex proteomes by 
comparing the rates of binding of the ser-
ine hydrolases to the FP-biotin probes in the 
control and OTFMK-treated samples (Kidd 
et al. 2001). An in vitro assay exposing puri-
fied tubulin to an OP–biotin probe demon-
strated not only that OPs bind this previously 
unidentified target, but also that they bind 
tyrosine residues in tubulin. The OP-reactive 
tyrosine residues reside either near the GTP 
binding site or within loops that interact later-
ally with proto  filaments, indicating that this 
binding, if it occurs in vivo, may lead to non-
cholinergic toxic outcomes (Grigoryan et al. 
2008). Lockridge and colleagues (Ding et al. 
2008; Schopfer et al. 2005a, 2005b) also 
used FP-biotin combined with MS to iden-
tify OP-modified proteins in human plasma. 
The plasma was treated with FP-biotin; the 
proteins were separated into low- and high-
abundance portions and digested with trypsin; 
and the FP-biotinylated peptides were isolated 
by binding to avidin beads. Proteins identi-
fied in these studies included albumin, ES1 
carboxylesterase, propionyl and methyl  crotonyl 
coenzyme A carboxylase-α, and pyruvate car-
boxylase. The investigators were able to readily 
identify FP-biotin–labeled albumin because of 
its high concentration in human plasma (Ding 
et al. 2008; Schopfer et al. 2005a, 2005b). 
The results demon  strated that albumin is an 
OP scavenger and undergoes a covalent reac-
tion with OP on five tyrosines and two serines 
(Aardema and MacGregor 2002; Peeples et al. 
2005; Schopfer et al. 2005a, 2005b; Wieseler 
et al. 2006). Although the FP-biotin probe 
was unable to identify any additional novel OP 
protein targets, the results from this study sug-
gest that OP–albumin adducts could be used 
to monitor OP exposure (Ding et al. 2008).
FP-biotin has a relatively large structure 
compared with OPs, so it can be argued that 
this probe may react differently with various 
proteins in biological systems and possibly fail to 
detect important OP protein targets. This could 
prove to be problematic with enzymes such 
as AChE and BChE that contain OP binding 
sites located deep within the molecule. Schopfer 
et al. (2005a, 2005b) investigated the rates of 
reactivity and binding affinity of FP-biotin 
with AChE and BChE. The results from their 
study demonstrate that, despite its large biotin 
group, FP-biotin reacts with both AChE and 
BChE at rates comparable to reaction rates of 
other OPs. Therefore, the authors concluded 
that FP-biotin is a potent OP and can serve 
as a useful probe for identifying OP protein 
targets. Taken together, the studies described 
here demon  strate that molecular probes such 
as biotinylated OPs can be powerful tools for 
proteomic studies. Although FP-biotin does not 
precisely simulate OP structure, the ability to 
rapidly isolate and identify labeled proteins in 
crude cell and tissue extracts, as well as provide 
insight into post  translational events that regu-
late protein function, outweighs some of the 
potential limitations.
Conclusions
The mechanisms by which OP insecticide 
oxons covalently adduct AChE, BChE, and 
other serine hydrolases have been relatively 
well understood, but many of the post-
inhibition processes have not been well char-
acterized. Advances in protein MS have clearly 
aided investigators with a new and power-
ful tool to interpret not only the adduction 
event but also the molecular steps that occur 
after adduction. As a result, it is now some-
what routine to investigate not only OP–ChE 
adduct formation but also each step in the 
process that leads to injurious modifications 
of the protein. With these important steps 
accomplished, investigators can now broaden 
the scope of their inquiry into how proteins 
other than cholinesterases are modified by OP 
compounds and, hence, how the connected 
cellular level events may be compromised.
RefeRences
Aardema MJ, MacGregor JT. 2002. Toxicology and genetic 
toxicology in the new era of “toxicogenomics”: impact of 
“-omics” technologies. Mutat Res 499:13–25.
Adam GC, Cravatt BF, Sorensen EJ. 2001. Profiling the specific 
reactivity of the proteome with non-directed activity-based 
probes. Chem Biol 8:81–95.
Adam GC, Sorensen EJ, Cravatt BF. 2002. Trifunctional chemi-
cal probes for the consolidated detection and identifica-
tion of enzyme activities from complex proteomes. Mol 
Cell Proteomics 1:828–835.
Adamczyk M, Gebler JC, Wu J. 2001. Selective analysis of phos-
phopeptides within a protein mixture by chemical modi-
fi  cation, reversible biotinylation and mass spectrometry. 
Rapid Commun Mass Spectrom 15:1481–1488.
Albuquerque  EX,  Aracava  Y,  Cintra  WM,  Brossi  A, 
Schonenberger B, Deshpande SS. 1988. Structure-activity 
relationship of reversible cholinesterase inhibitors: activa-
tion, channel blockade and stereospecificity of the nicotinic 
acetylcholine receptor-ion channel complex. Braz J Med 
Biol Res 21:1173–1196.
Arima H, Sobue K, So M, Morishima T, Ando H, Katsuya H. 2003. 
Transient and reversible parkinsonism after acute organo-
phosphate poisoning. J Toxicol Clin Toxicol 41:67–70.
Ashani Y, Gentry MK, Doctor BP. 1990. Differences in conforma-
tional stabilty between native and phosphorylated acetyl-
cholinesterase as evidenced by a monoclonal antibody. 
Biochemistry 29:2456–2463.
Ashani Y, Leader H, Rothschild N, Dosoretz C. 1998. Combined 
effect of organophosphorus hydrolase and oxime on the 
reactivation rate of diethylphosphoryl-acetylcholinesterase 
conjugates. Biochem Pharmacol 55:159–168.
Ashani Y, Radic Z, Tsigelny I, Vellom DC, Pickering NA, 
Quinn DM, et al. 1995. Amino acid residues controlling 
reactivation of organophosphonyl conjugates of acetyl-
cholinesterase by mono- and bisquaternary oximes. J Biol 
Chem 270:6370–6380.
Ballantyne B, Marrs T. 1992. Clinical and Experimental Toxicology 
of Organophosphates and Carbamates. Boston:Butterworth 
Heinemann.
Barak R, Ordentlich A, Barak D, Fischer M, Benschop HP, 
De Jong LPA, et al. 1997. Direct determination of the chemi-
cal composition of acetylcholinesterase phos  phonylation 
products utilizing electrospray-ionization mass spectrom-
etry. FEBS Lett 407:347–352.
Barr DB, Allen R, Olsson AO, Bravo R, Caltabiano LM, 
Montesano A, et al. 2005. Concentrations of selective 
metabolites of organophosphorus pesticides in the United 
States population. Environ Res 99:314–326.
Bennett KL, Stensballe A, Podtelejnikov AV, Moniatte M, 
Jensen ON. 2002. Phosphopeptide detection and sequencing 
by matrix-assisted laser desorption/ionization quadru  pole 
time-of-flight tandem mass spectrometry. J Mass Spectrom 
37:179–190.
Berkman CE, Quinn DA, Thompson CM. 1993a. Interaction of 
acetylcholinesterase with the enantiomers of malaoxon 
and isomalathion. Chem Res Toxicol 6:724–730.
Berkman CE, Ryu S, Quinn DA, Thompson CM. 1993b. Kinetics 
of the postinhibitory reactions of acetylcholinesterase poi-
soned by chiral isomalathion: a surprising nonreactivation 
induced by the RP stereoisomers. Chem Res Toxicol 6:28–32.
Berkman CE, Thompson CM, Perrin SR. 1993c. Synthesis, abso-
lute configuration, and analysis of malathion, malaoxon, and 
isomalathion enantiomers. Chem Res Toxicol 6:718–723.
Bomser J, Casida JE. 2000. Activation of extracellular signal- 
regulated kinases (ERK 44/42) by chlorpyrifos oxon in 
Chinese hamster ovary cells. J Biochem Mol Toxicol 
14:346–353.
Bomser JA, Casida JE. 2001. Diethylphosphorylation of rat car-
diac M2 muscarinic receptor by chlorpyrifos oxon in vitro. 
Toxicol Lett 119:21–26.
Bomser JA, Quistad GB, Casida JE. 2002. Chlorpyrifos oxon 
potentiates diacylglycerol-induced extracellular signal-
regulated kinase (ERK 44/42) activation, possibly by 
diacylglycerol lipase inhibition. Toxicol Appl Pharmacol 
178:29–36.
Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, 
Heard SE. 2008. 2007 Annual report of the American 
Association of Poison Control Centers’ National Poison 
Data System (NPDS): 25th annual report. Clin Toxicol (Phila) 
46:927–1057.
Broomfield CA, Millard CB, Lockridge O, Caviston TL. 1995. 
Enzymes of the Cholinesterase Family. New York:Plenum 
Press.
Casida JE, Quistad GB. 2005. Serine hydrolase targets of organo-
phosphorus toxicants. Chem Biol Interact 157–158:277–283.
Centers for Disease Control and Prevention. 2005. Third 
National Report on Human Exposure to Environmental 
Chemicals. Available: http://www.cdc.gov/exposurereport/
pdf/thirdreport.pdf [accessed 17 November 2009].
Claudio L, Kwa WC, Russell AL, Wallinga D. 2000. Testing methods 
for developmental neurotoxicity of environmental chemicals. 
Toxicol Appl Pharmacol 164:1–14.
Corrigan  FM,  MacDonald  S,  Brown  A,  Armstrong  K, 
Armstrong EM. 1994. Neurasthenic fatigue, chemical 
sensitivity and GABAa receptor toxins. Med Hypotheses 
43:195–200.
Costa LG. 1998. Neurotoxicity testing: a discussion of in vitro 
alternatives. Environ Health Perspect 106(suppl 2):505–510.
Costa LG. 2006. Current issues in organophosphate toxicology. 
Clin Chim Acta 366:1–13.
Costa LG, Cole TB, Vitalone A, Furlong CE. 2005. Measurement 
of paraoxonase (PON1) status as a potential biomarker of 
susceptibility to organophosphate toxicity. Clin Chim Acta 
352:37–47.
Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. 
2003. Paraoxonase (PON 1) as a biomarker of susceptibility 
for organophosphate toxicity. Biomarkers 8:1–12.
Dahlgren JG, Takhar HS, Ruffalo CA, Zwass M. 2004. Health 
effects of diazinon on a family. J Toxicol Clin Toxicol 
42:579–591.
Ding SJ, Carr J, Carlson JE, Tong L, Xue W, Li Y, et al. 2008. Five 
tyrosines and two serines in human albumin are labeled by 
the organophosphorus agent FP-biotin. Chem Res Toxicol 
21:1787–1794.
Doorn JA, Gage DA, Schall M, Talley TT, Thompson CM, 
Richardson RJ. 2000. Inhibition of acetylcholinesterase Thompson et al.
18  v o l u m e  118 | n u m b e r 1 | January 2010  •  Environmental Health Perspectives
by (1S,3S)-isomalathion proceeds with loss of thiomethyl: 
kinetic and mass spectral evidence for an unexpected pri-
mary leaving group. Chem Res Toxicol 13:1313–1320.
Doorn JA, Schall M, Gage DA, Talley TT, Thompson CM, 
Richardson RJ. 2001a. Identification of butyrylcholinest-
erase adducts after inhibition with isomalathion using mass 
spectrometry: difference in mechanism between (1R)- and 
(1S)-stereoisomers. Toxicol Appl Pharmacol 176:73–80.
Doorn JA, Talley TT, Thompson CM, Richardson RJ. 2001b. 
Probing the active sites of butyrylcholinesterase and choles-
terol esterase with isomalathion: conserved stereo  selective 
inactivation of serine hydrolases structurally related to 
acetyl  cholinesterase. Chem Res Toxicol 14:807–813.
Ehrich M, Intropido L, Costa LG. 1994. Interaction of organo-
phosphorus compounds with muscarinic receptors in 
SH-SY5Y human neuroblastoma cells. J Toxicol Environ 
Health 43:51–63.
Eldefrawi ME, Eldefrawi AT. 1983. Neurotransmitter receptors 
as targets for pesticides. J Environ Sci Health B 18:65–88.
Elhanany E, Ordentlich A, Dgany O, Kaplan D, Segall Y, Barak R, 
et al. 2001. Resolving pathways of interaction of covalent 
inhibitors with the active site of acetylcholinesterases: 
MALDI-TOF/MS analysis of various nerve agent phosphyl 
adducts. Chem Res Toxicol 14:912–918.
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. 
A new and rapid colorimetric determination of acetyl-
cholinesterase activity. Biochem Pharmacol 7:88–95.
Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB, Johnson C, 
et al. 2007. Organophosphate pesticide exposure and 
neurodevelopment in young Mexican-American children. 
Environ Health Perspect 115:792–798.
Eto M. 1974. Organophosphorus Pesticides; Organic and 
Biological Chemistry. Cleveland, OH:CRC Press.
Fenske RA, Kissel JC, Lu C, Kalman DA, Simcox NJ, Allen EH, 
et al. 2000. Biologically based pesticide dose estimates 
for children in an agricultural community. Environ Health 
Perspect 108:515–520.
Fest C, Schmidt KJ. 1973. The Chemistry of Organophosphorus 
Pesticides; Reactivity, Synthesis, Mode of Action, 
Toxicology. New York:Springer Verlag.
Fukuto TR. 1990. Mechanism of action of organophosphorus and 
carbamate insecticides. Environ Health Perspect 87:245–254.
Godovac-Zimmermann J, Soskic V, Poznanovic S, Brianza  F. 
1999. Functional proteomics of signal transduction by 
membrane receptors. Electrophoresis 20:952–961.
Goldman LR, Koduru S. 2000. Chemicals in the environment and 
developmental toxicity to children: a public health and policy 
perspective. Environ Health Perspect 108(suppl 3):443–448.
Gordon C. 1993. Acute and delayed effects of diisopropyl  fluoro-
phosphate on body temperature, heart rate, and motor 
activity in the awake, unrestrained rat. J Toxic Environ 
Health 39:247–260.
Grigoryan H, Schopfer LM, Thompson CM, Terry AV, Masson P, 
Lockridge O. 2008. Mass spectrometry identifies covalent 
binding of soman, sarin, chlorpyrifos oxon, diisopropyl 
fluoro  phosphate, and FP-biotin to tyrosines on tubulin: a 
potential mechanism of long term toxicity by organophos-
phorus agents. Chem Biol Interact 175:180–186.
Haas R, Jackson B, Reinhold B, Foster J, Rosenberry T. 1996. 
Glycoinositol phospholipid anchor and protein C-terminus 
of bovine erythrocyte acetylcholinesterase: analysis by 
mass spectrometry and by protein and DNA sequencing. 
Biochem J 314:817–825.
Haas R, Rosenberry T. 1995. Protein denaturation by addition 
and removal of acetonitrile: application to tryptic digestion 
of acetylcholinesterase. Anal Biochem 224:425–427.
Harel M, Su CT, Frolow F, Ashani Y, Silman I, Sussman JL. 
1991. Refined crystal structures of “aged” and “non-aged” 
organophosphoryl conjugates of gamma-chymotrypsin. 
J Mol Biol 221:909–918.
Huff RA, Corcoran JJ, Anderson JK, Abou-Donia MB. 1994. 
Chlorpyrifos oxon binds directly to muscarinic receptors and 
inhibits cAMP accumulation in rat striatum. J Pharmacol 
Exp Ther 269:329–335.
Jacobson SW, Jacobson JL. 2006. New evidence of effects 
of organophosphate pesticides on neurodevelopment in 
children: commentary on the article by Kofman et al. on 
page 88. Pediatr Res 60:22–23.
Jayawardane P, Dawson AH, Weerasinghe V, Karalliedde L, 
Buckley NA, Senanayake N. 2008. The spectrum of interme-
diate syndrome following acute organophosphate poisoning: 
a prospective cohort study from Sri Lanka. PLoS Med 5:e147; 
doi:10.1371/journal.pmed.0050147 [Online 15 July 2008].
Jennings LL, Malecki M, Komives EA, Taylor P. 2003. Direct 
analysis of the kinetic profiles of organophosphate-acetyl-
cholinesterase adducts by MALDI-TOF mass spectrometry. 
Biochemistry 42:11083–11091.
Jiang X, Wang Y. 2004. Beta-elimination coupled with tandem 
mass spectrometry for the identification of in vivo and 
in vitro phosphorylation sites in maize dehydrin DHN1 
protein. Biochemistry 43:15567–15576.
Johal MS, Sharma ML, Ravneet. 2007. Impact of low dose of 
organophosphate, monocrotophos on the epithelial cells 
of gills of Cyprinus carpio communis Linn.—SEM study. 
J Environ Biol 28:663–667.
Katz L, Marquis J. 1992. Organophosphate-induced alteration in 
muscarinic receptor binding and phosphoinositide hydrolysis 
in the human SK-N-SH cell line. Neurotoxicology 13:365–378.
Kidd D, Liu Y, Cravatt BF. 2001. Profiling serine hydrolase activities 
in complex proteomes. Biochemistry 40:4005–4015.
Kofman O, Berger A, Massarwa A, Friedman A, Jaffar AA. 2006. 
Motor inhibition and learning impairments in school-aged 
children following exposure to organophosphate pesticides 
in infancy. Pediatr Res 60:88–92.
Langenberg JP, De Jong LP, Otto MF, Benschop HP. 1988. 
Spontaneous and oxime-induced reactivation of acetyl-
cholinesterase inhibited by phosphoramidates. Arch 
Toxicol 62:305–310.
Lanks KW, Seleznick MJ. 1981. Spontaneously reactivation of 
acetylcholinesterase inhibited by diisopropylfluorophos-
phate. Biochim Biophys Acta 660:91–95.
Larsen MR, Sørensen GL, Fey SJ, Larsen PM, Roepstorff P. 
2001. Phospho-proteomics: evaluation of the use of 
enzymatic de-phosphorylation and differential mass 
spectrometric peptide mass mapping for site specific 
phosphorylation assignment in proteins separated by gel 
electrophoresis. Proteomics 1:223–238.
Li Y, Li M, Xing G, Hu Z, Wang Q, Dong C, et al. 2000a. 
Stimulation of the mitogen-activated protein kinase 
cascade and tyrosine phosphorylation of the epidermal 
growth factor receptor by hepatopoietin. J Biol Chem 
275:37443–37447.
Li Y, Liu L, Kang J, Sheng JG, Barger SW, Mrak RE, et al. 2000b. 
Neuronal-glial interactions mediated by inter  leukin-1 
enhance neuronal acetylcholinesterase activity and mRNA 
expression. J Neurosci 20:149–155.
Liu Y, Patricelli MP, Cravatt BF. 1999. Activity-based protein 
profiling: the serine hydrolases. Proc Natl Acad Sci USA 
96:14694–14699.
Lockridge O, Masson P. 2000. Pesticides and susceptible popu-
lations: people with butyrylcholinesterase genetic variants 
may be at risk. Neurotoxicology 21:113–126.
Lotti M, Becker CE, Aminoff MJ. 1984. Organophosphate poly-
neuropathy: pathogenesis and prevention. Neurology 
34:658–662.
Menzies GW, MacConnell CB. 1998. Integrated Pest Management 
for Raspberries: A Guide for Sampling and Decision-Making 
for Key Raspberry Pests in Northwest Washington. Available: 
http://whatcom.wsu.edu/ag/comhort/nooksack/ipmweb/
Pesticideselection.html [accessed 17 November 2009]. 
Murray A, Rathbone A, Ray D. 2005. Novel protein targets for 
organophosphorus pesticides in rat brain. Environ Toxicol 
Pharmacol 19:451–454.
National Center for Biotechnology Information. 2009. PubMed. 
Available: http://www.ncbi.nlm.nih.gov/pubmed/ [accessed 
17 November 2009]. 
Niven AS, Roop SA. 2004. Inhalational exposure to nerve 
agents. Respir Care Clin N Am 10:59–74.
Nomura DK, Durkin KA, Chiang KP, Quistad GB, Cravatt BF, 
Casida JE. 2006. Serine hydrolase KIAA1363: toxicological 
and structural features with emphasis on organophos-
phate interactions. Chem Res Toxicol 19:1142–1150.
Noort D, Fidder A, van der Schans MJ, Hulst AG. 2006. 
Verification of exposure to organophosphates: generic 
mass spectrometric method for detection of human butyryl-
cholinesterase adducts. Anal Chem 78:6640–6644.
Pala I, Vig PJ, Desaiah D, Srinivasan A. 1991. In vitro effects 
of organophosphorus compounds on calmodulin activity. 
J Appl Toxicol 11:391–395.
Peeples ES, Schopfer LM, Duysen EG, Spaulding R, Voelker T, 
Thompson CM, et al. 2005. Albumin, a new biomarker of 
organophosphorus toxicant exposure, identified by mass 
spectrometry. Toxicol Sci 83:303–312.
Qian WJ, Goshe MB, Camp DG II, Yu LR, Tang K, Smith RD. 
2003. Phosphoprotein isotope-coded solid-phase tag 
approach for enrichment and quantitative analysis of 
phosphopeptides from complex mixtures. Anal Chem 
75:5441–5450.
Quistad GB, Casida JE. 2000. Sensitivity of blood-clotting factors 
and digestive enzymes to inhibition by organophosphorus 
pesticides. J Biochem Mol Toxicol 14:51–56.
Quistad GB, Sparks SE, Casida JE. 2001. Fatty acid amide 
hydrolase inhibition by neurotoxic organophosphorus 
pesticides. Toxicol Appl Pharmacol 173:48–55.
Quistad GB, Zhang N, Sparks SE, Casida JE. 2000. Phospho-
acetyl  cholinesterase: toxicity of phosphorus oxychloride 
to mammals and insects that can be attributed to selective 
phosphorylation of acetylcholinesterase by phosphoro-
dichloridic acid. Chem Res Toxicol 13:652–657.
Richards P, Johnson M, Ray D, Walker C. 1999. Novel protein 
targets for organophosphorus compounds. Chem Biol 
Interact 119–120:503–511.
Roberts WL, Santikarn S, Reinhold VN, Rosenberry TL. 
1988. Structural characterization of the glycoinositol 
phospho  lipid membrane anchor of human erythrocyte 
acetyl  cholinesterase by fast atom bombardment mass 
spectrometry. J Biol Chem 263:18776–18784.
Rowsey PJ, Gordon CJ. 1999. Tumor necrosis factor is involved 
in chlorpyrifos-induced changes in core temperature in 
the female rat. Toxicol Lett 109:51–59.
Schopfer LM, Champion MM, Tamblyn N, Thompson CM, 
Lockridge O. 2005a. Characteristic mass spectral frag-
ments of the organophosphorus agent FP-biotin and 
FP-biotinylated peptides from trypsin and bovine albumin 
(Tyr410). Anal Biochem 345:122–132.
Schopfer LM, Voelker T, Bartels CF, Thompson CM, Lockridge O. 
2005b. Reaction kinetics of biotinylated organophosphorus 
toxicant, FP-biotin, with human acetyl  cholinesterase and 
human butyrylcholinesterase. Chem Res Toxicol 18:747–754.
Schuh RA, Lein PJ, Beckles RA, Jett DA. 2002. Noncholinesterase 
mechanisms of chlorpyrifos neurotoxicity: altered phos-
phorylation of Ca2+/cAMP response element binding protein 
in cultured neurons. Toxicol Appl Pharmacol 182:176–185.
Sickmann A, Meyer HE. 2001. Phosphoamino acid analysis. 
Proteomics 1:200–206.
Slotkin TA. 2004. Cholinergic systems in brain development 
and disruption by neurotoxicants: nicotine, environmental 
tobacco smoke, organophosphates. Toxicol Appl Pharmacol 
198:132–151.
Slotkin TA, Ryde IT, Levin ED, Seidler FJ. 2008. Developmental 
neurotoxicity of low dose diazinon exposure of neonatal 
rats: effects on serotonin systems in adolescence and 
adulthood. Brain Res Bull 75:640–647.
Solomon C, Poole J, Palmer KT, Peveler R, Coggon D. 2007. 
Acute symptoms following work with pesticides. Occup 
Med (Lond) 57:505–511.
Spaulding RS, George KM, Thompson CM. 2006. Analysis and 
sequencing of the active-site peptide from native and 
organophosphate-inactivated acetylcholinesterase by 
electrospray ionization, quadrupole/time-of-flight (QTOF) 
mass spectrometry. J Chromatogr B Analyt Technol 
Biomed Life Sci 830:105–113.
Stephens R, Spurgeon A, Calvert IA, Beach J, Levy LS, Berry H, 
et al. 1995. Neuropsychological effects of long-term exposure 
to organophosphates in sheep dip. Lancet 345:1135–1139.
Sudakin DL, Power LE. 2007. Organophosphate exposures in 
the United States: a longitudinal analysis of incidents 
reported to poison centers. J Toxicol Environ Health A 
70:141–147.
Sultatos LG. 1994. Mammalian toxicology of organophosphorus 
pesticides. J Toxicol Environ Health 43:271–289.
Swiss Institute of Bioinformatics. 2007. PeptideCutter. 
Available: http://www.expasy.org/tools/peptidecutter/ 
[accessed 17 November 2009]. 
Thaler F, Valsasina B, Baldi R, Xie J, Stewart A, Isacchi A, et al. 
2003. A new approach to phosphoserine and phospho-
threonine analysis in peptides and proteins: chemical 
modifi  cation, enrichment via solid-phase reversible binding, 
and analysis by mass spectrometry. Anal Bioanal Chem 
376:366–373.
Thompson CM, Fukuto TR. 1982. Mechanism of cholinest-
erase inhibition by methamidophos. J Agric Food Chem 
30:282–284.
Timofeeva OA, Roegge CS, Seidler FJ, Slotkin TA, Levin ED. 
2008. Persistent cognitive alterations in rats after early 
postnatal exposure to low doses of the organophosphate 
pesticide, diazinon. Neurotoxicol Teratol 30:38–45.
Tseng HC, Ovaa H, Wei NJ, Ploegh H, Tsai LH. 2005. Phospho-
proteomic analysis with a solid-phase capture-release-tag 
approach. Chem Biol 12:769–777.
U.S. EPA. 2006. Organophosphorus Cumulative Risk 
Assessment (2006 Update). EPA-HQ-OPP-2006-0618-0002. Mass spectrometry of organophosphate–protein adducts
Environmental Health Perspectives  •  v o l u m e  118 | n u m b e r 1 | January 2010  19
Washington, DC:U.S. Environmental Protection Agency. 
Available: http://www.regulations.gov/search/Regs/home.
html#documentDetail?R=09000064801ac312 [accessed 
17 November 2009].
van den Beukel I, van Kleef RG, Oortgiesen M. 1998. Differential 
effects of physostigmine and organophosphates on nico-
tinic receptors in neuronal cells of different species. 
Neurotoxicology 19:777–787.
Ward TR, Ferris DJ, Tilson HA, Mundy WR. 1993. Correlation 
of the anticholinesterase activity of a series of organo-
phosphates with their ability to compete with agonist 
binding to muscarinic receptors. Toxicol Appl Pharmacol 
122:300–307.
Ward TR, Mundy WR. 1996. Organophosphorus compounds 
preferentially affect second messenger systems coupled 
to M2/M4 receptors in rat frontal cortex. Brain Res Bull 
39:49–55.
Whyatt RM, Camann D, Perera FP, Rauh VA, Tang D, Kinney PL, 
et al. 2005. Biomarkers in assessing residential insecticide 
exposures during pregnancy and effects on fetal growth. 
Toxicol Appl Pharmacol 206:246–254.
Whyatt RM, Rauh V, Barr DB, Camann DE, Andrews HF, 
Garfinkel R, et al. 2004. Prenatal insecticide exposures and 
birth weight and length among an urban minority cohort. 
Environ Health Perspect 112:1125–1132.
Wieseler S, Schopfer L, Lockridge O. 2006. Markers of organo-
phosphate exposure in human serum. J Mol Neurosci 
30:93–94.
Wilson BW, Henderson JD. 1992. Blood esterase determina-
tions as markers of exposure. Rev Environ Contam Toxicol 
128:55–69.
Wilson BW, Hooper MJ, Hansen ME, Nieberg PS. 1992. 
Reactivation of organophosphorus inhibited AChE with 
oximes. In: Organophosphates: Chemistry, Fate, and Effects 
(Chambers JE, Levi PE, eds). San Diego, CA:Academic 
Press, 107–137.
Wilson BW, Padilla S, Henderson JD, Brimijoin S, Dass PD, 
Elliot G, et al. 1996. Factors in standardizing automated cho-
linesterase assays. J Toxicol Environ Health 48:187–195.
Yanagisawa N, Morita H, Nakajima T. 2006. Sarin experiences 
in Japan: acute toxicity and long-term effects. J Neurol 
Sci 249:76–85.
Young JG, Eskenazi B, Gladstone EA, Bradman A, Pedersen L, 
Johnson C, et al. 2005. Association between in utero organo-
phosphate pesticide exposure and abnormal reflexes in 
neonates. Neurotoxicology 26:199–209.
Zaim M, Jambulingam P. 2007. Global Insecticide Use for 
Vector-Borne Disease Control. Geneva:World Health 
Organization. Available: http://whqlibdoc.who.int/HQ/2007/
WHO_CDS_NTD_WHOPES_GCDPP_2007.2_eng.pdf 
[accessed 17 November 2009]. 
Zwiener RJ, Ginsburg CM. 1988. Organophosphate and car-
bamate poisoning in infants and children. Pediatrics 
81:121–126.